No Data
No Data
When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Turn A Profit?
Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)
Analysts Hunt for Undervalued Biotech Stocks
Express News | EF Hutton Initiates Coverage On Citius Pharma With Buy Rating, Announces Price Target of $6
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR): Are Analysts Optimistic?
Biopharma Stocks Transformative Innovation for the Future of Health
No Data
Jenna Ragan : RIGL!! RIGL!!![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Trytosaveabit OP Jenna Ragan : Hehehe! Yes ma’am pretty lady! I just knew that one would get you attention! Hehehe. Thanks for the smile you just gave me! Hehehe![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Jenna Ragan Trytosaveabit OP : You are very welcome![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Seraphicall : CMMB yes.
but you have these many holdings?